Financial toxicity among head and neck cancer patients and their caregivers: A cross‐sectional pilot study
Objectives Head and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has concentrated on patients despite many informal caregivers sharing finances and reducing work hours to provide patient care. Thus, our pilot study: (1) a...
Saved in:
Published in | Laryngoscope investigative otolaryngology Vol. 8; no. 2; pp. 450 - 457 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.04.2023
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objectives
Head and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has concentrated on patients despite many informal caregivers sharing finances and reducing work hours to provide patient care. Thus, our pilot study: (1) assessed the feasibility of financial toxicity screening of HNC patients and their caregivers, and (2) described financial toxicity levels of HNC patients and their caregivers.
Methods
We surveyed English‐speaking adult HNC patients initiating treatment at a National Cancer Institute‐designated Comprehensive Cancer Center and their informal caregivers. This survey assessed demographics and financial toxicity through the Comprehensive Score for Financial Toxicity (COST) measure (0–44 range; lower score indicates higher financial toxicity). Screening feasibility was defined as ≥50% consent rate and ≥60% data completion rate.
Results
Our sample included 27 HNC patients and 9 caregivers. They both had slightly lower consent and completion rates than our goals. Patients reported a median COST score of 27 while caregivers reported a median COST score of 16. Approximately 25.9% of patients and 44.4% of caregivers reported high financial toxicity (COST < 17.5). Caregivers reported high concerns about their future financial health and their ability to control the amount of their financial contributions to the patient's care.
Conclusions
Patients and caregivers may require additional outreach approaches beyond emailed questionnaires to screen for their financial toxicity systematically. Future research is needed to replicate our results to determine whether differences in financial toxicity occur between patients and caregivers and identify areas of focus for interventions.
Level of evidence
IV.
Our pilot study administered the Comprehensive Score for Financial Toxicity (COST) measure to head and neck cancer patients and their caregivers. We found that approximately 25.9% of patients and 44.4% of caregivers reported high financial toxicity (COST<17.5). Caregivers reported high concerns about their future financial health and their ability to control the amount of their financial contributions to the patient's care. |
---|---|
AbstractList | Objectives
Head and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has concentrated on patients despite many informal caregivers sharing finances and reducing work hours to provide patient care. Thus, our pilot study: (1) assessed the feasibility of financial toxicity screening of HNC patients and their caregivers, and (2) described financial toxicity levels of HNC patients and their caregivers.
Methods
We surveyed English‐speaking adult HNC patients initiating treatment at a National Cancer Institute‐designated Comprehensive Cancer Center and their informal caregivers. This survey assessed demographics and financial toxicity through the Comprehensive Score for Financial Toxicity (COST) measure (0–44 range; lower score indicates higher financial toxicity). Screening feasibility was defined as ≥50% consent rate and ≥60% data completion rate.
Results
Our sample included 27 HNC patients and 9 caregivers. They both had slightly lower consent and completion rates than our goals. Patients reported a median COST score of 27 while caregivers reported a median COST score of 16. Approximately 25.9% of patients and 44.4% of caregivers reported high financial toxicity (COST < 17.5). Caregivers reported high concerns about their future financial health and their ability to control the amount of their financial contributions to the patient's care.
Conclusions
Patients and caregivers may require additional outreach approaches beyond emailed questionnaires to screen for their financial toxicity systematically. Future research is needed to replicate our results to determine whether differences in financial toxicity occur between patients and caregivers and identify areas of focus for interventions.
Level of evidence
IV.
Our pilot study administered the Comprehensive Score for Financial Toxicity (COST) measure to head and neck cancer patients and their caregivers. We found that approximately 25.9% of patients and 44.4% of caregivers reported high financial toxicity (COST<17.5). Caregivers reported high concerns about their future financial health and their ability to control the amount of their financial contributions to the patient's care. Head and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has concentrated on patients despite many informal caregivers sharing finances and reducing work hours to provide patient care. Thus, our pilot study: (1) assessed the feasibility of financial toxicity screening of HNC patients and their caregivers, and (2) described financial toxicity levels of HNC patients and their caregivers. We surveyed English-speaking adult HNC patients initiating treatment at a National Cancer Institute-designated Comprehensive Cancer Center and their informal caregivers. This survey assessed demographics and financial toxicity through the Comprehensive Score for Financial Toxicity (COST) measure (0-44 range; lower score indicates higher financial toxicity). Screening feasibility was defined as ≥50% consent rate and ≥60% data completion rate. Our sample included 27 HNC patients and 9 caregivers. They both had slightly lower consent and completion rates than our goals. Patients reported a median COST score of 27 while caregivers reported a median COST score of 16. Approximately 25.9% of patients and 44.4% of caregivers reported high financial toxicity (COST < 17.5). Caregivers reported high concerns about their future financial health and their ability to control the amount of their financial contributions to the patient's care. Patients and caregivers may require additional outreach approaches beyond emailed questionnaires to screen for their financial toxicity systematically. Future research is needed to replicate our results to determine whether differences in financial toxicity occur between patients and caregivers and identify areas of focus for interventions. IV. Abstract Objectives Head and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has concentrated on patients despite many informal caregivers sharing finances and reducing work hours to provide patient care. Thus, our pilot study: (1) assessed the feasibility of financial toxicity screening of HNC patients and their caregivers, and (2) described financial toxicity levels of HNC patients and their caregivers. Methods We surveyed English‐speaking adult HNC patients initiating treatment at a National Cancer Institute‐designated Comprehensive Cancer Center and their informal caregivers. This survey assessed demographics and financial toxicity through the Comprehensive Score for Financial Toxicity (COST) measure (0–44 range; lower score indicates higher financial toxicity). Screening feasibility was defined as ≥50% consent rate and ≥60% data completion rate. Results Our sample included 27 HNC patients and 9 caregivers. They both had slightly lower consent and completion rates than our goals. Patients reported a median COST score of 27 while caregivers reported a median COST score of 16. Approximately 25.9% of patients and 44.4% of caregivers reported high financial toxicity (COST < 17.5). Caregivers reported high concerns about their future financial health and their ability to control the amount of their financial contributions to the patient's care. Conclusions Patients and caregivers may require additional outreach approaches beyond emailed questionnaires to screen for their financial toxicity systematically. Future research is needed to replicate our results to determine whether differences in financial toxicity occur between patients and caregivers and identify areas of focus for interventions. Level of evidence IV. Our pilot study administered the Comprehensive Score for Financial Toxicity (COST) measure to head and neck cancer patients and their caregivers. We found that approximately 25.9% of patients and 44.4% of caregivers reported high financial toxicity (COST<17.5). Caregivers reported high concerns about their future financial health and their ability to control the amount of their financial contributions to the patient's care. Abstract Objectives Head and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has concentrated on patients despite many informal caregivers sharing finances and reducing work hours to provide patient care. Thus, our pilot study: (1) assessed the feasibility of financial toxicity screening of HNC patients and their caregivers, and (2) described financial toxicity levels of HNC patients and their caregivers. Methods We surveyed English‐speaking adult HNC patients initiating treatment at a National Cancer Institute‐designated Comprehensive Cancer Center and their informal caregivers. This survey assessed demographics and financial toxicity through the Comprehensive Score for Financial Toxicity (COST) measure (0–44 range; lower score indicates higher financial toxicity). Screening feasibility was defined as ≥50% consent rate and ≥60% data completion rate. Results Our sample included 27 HNC patients and 9 caregivers. They both had slightly lower consent and completion rates than our goals. Patients reported a median COST score of 27 while caregivers reported a median COST score of 16. Approximately 25.9% of patients and 44.4% of caregivers reported high financial toxicity (COST < 17.5). Caregivers reported high concerns about their future financial health and their ability to control the amount of their financial contributions to the patient's care. Conclusions Patients and caregivers may require additional outreach approaches beyond emailed questionnaires to screen for their financial toxicity systematically. Future research is needed to replicate our results to determine whether differences in financial toxicity occur between patients and caregivers and identify areas of focus for interventions. Level of evidence IV. Our pilot study administered the Comprehensive Score for Financial Toxicity (COST) measure to head and neck cancer patients and their caregivers. We found that approximately 25.9% of patients and 44.4% of caregivers reported high financial toxicity (COST<17.5). Caregivers reported high concerns about their future financial health and their ability to control the amount of their financial contributions to the patient's care. ObjectivesHead and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has concentrated on patients despite many informal caregivers sharing finances and reducing work hours to provide patient care. Thus, our pilot study: (1) assessed the feasibility of financial toxicity screening of HNC patients and their caregivers, and (2) described financial toxicity levels of HNC patients and their caregivers.MethodsWe surveyed English-speaking adult HNC patients initiating treatment at a National Cancer Institute-designated Comprehensive Cancer Center and their informal caregivers. This survey assessed demographics and financial toxicity through the Comprehensive Score for Financial Toxicity (COST) measure (0–44 range; lower score indicates higher financial toxicity). Screening feasibility was defined as ≥50% consent rate and ≥60% data completion rate.ResultsOur sample included 27 HNC patients and 9 caregivers. They both had slightly lower consent and completion rates than our goals. Patients reported a median COST score of 27 while caregivers reported a median COST score of 16. Approximately 25.9% of patients and 44.4% of caregivers reported high financial toxicity (COST < 17.5). Caregivers reported high concerns about their future financial health and their ability to control the amount of their financial contributions to the patient's care.ConclusionsPatients and caregivers may require additional outreach approaches beyond emailed questionnaires to screen for their financial toxicity systematically. Future research is needed to replicate our results to determine whether differences in financial toxicity occur between patients and caregivers and identify areas of focus for interventions.Level of evidenceIV. Head and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has concentrated on patients despite many informal caregivers sharing finances and reducing work hours to provide patient care. Thus, our pilot study: (1) assessed the feasibility of financial toxicity screening of HNC patients and their caregivers, and (2) described financial toxicity levels of HNC patients and their caregivers.ObjectivesHead and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has concentrated on patients despite many informal caregivers sharing finances and reducing work hours to provide patient care. Thus, our pilot study: (1) assessed the feasibility of financial toxicity screening of HNC patients and their caregivers, and (2) described financial toxicity levels of HNC patients and their caregivers.We surveyed English-speaking adult HNC patients initiating treatment at a National Cancer Institute-designated Comprehensive Cancer Center and their informal caregivers. This survey assessed demographics and financial toxicity through the Comprehensive Score for Financial Toxicity (COST) measure (0-44 range; lower score indicates higher financial toxicity). Screening feasibility was defined as ≥50% consent rate and ≥60% data completion rate.MethodsWe surveyed English-speaking adult HNC patients initiating treatment at a National Cancer Institute-designated Comprehensive Cancer Center and their informal caregivers. This survey assessed demographics and financial toxicity through the Comprehensive Score for Financial Toxicity (COST) measure (0-44 range; lower score indicates higher financial toxicity). Screening feasibility was defined as ≥50% consent rate and ≥60% data completion rate.Our sample included 27 HNC patients and 9 caregivers. They both had slightly lower consent and completion rates than our goals. Patients reported a median COST score of 27 while caregivers reported a median COST score of 16. Approximately 25.9% of patients and 44.4% of caregivers reported high financial toxicity (COST < 17.5). Caregivers reported high concerns about their future financial health and their ability to control the amount of their financial contributions to the patient's care.ResultsOur sample included 27 HNC patients and 9 caregivers. They both had slightly lower consent and completion rates than our goals. Patients reported a median COST score of 27 while caregivers reported a median COST score of 16. Approximately 25.9% of patients and 44.4% of caregivers reported high financial toxicity (COST < 17.5). Caregivers reported high concerns about their future financial health and their ability to control the amount of their financial contributions to the patient's care.Patients and caregivers may require additional outreach approaches beyond emailed questionnaires to screen for their financial toxicity systematically. Future research is needed to replicate our results to determine whether differences in financial toxicity occur between patients and caregivers and identify areas of focus for interventions.ConclusionsPatients and caregivers may require additional outreach approaches beyond emailed questionnaires to screen for their financial toxicity systematically. Future research is needed to replicate our results to determine whether differences in financial toxicity occur between patients and caregivers and identify areas of focus for interventions.IV.Level of evidenceIV. |
Author | Donato, Umberto Hong, Young‐Rock Nguyen, Oliver T. Alishahi Tabriz, Amir Turner, Kea Reblin, Maija Hume, Emma Patel, Krupal B. McCormick, Rachael Otto, Amy K. Kim, Lindsay Islam, Jessica Y. |
AuthorAffiliation | 2 College of Medicine, University of South Florida Tampa Florida USA 7 Department of Oncologic Sciences University of South Florida Tampa Florida USA 1 Department of Health Outcomes and Behavior H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA 6 Department of Public Health Sciences University of Miami Miller School of Medicine Miami Florida USA 9 Department of Cancer Epidemiology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA 3 University of Kansas Cancer Center Kansas City Kansas USA 8 Department of Gastrointestinal Oncology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA 4 Department of Family Medicine University of Vermont Burlington Vermont USA 5 Cancer Control and Population Health Sciences Program University of Vermont Cancer Center Burlington Vermont USA 11 Department of Health Services, Research, and Management University of Florida Gainesville Florida USA 10 Center for Immunization and Infection Research in Cancer, H. Lee |
AuthorAffiliation_xml | – name: 4 Department of Family Medicine University of Vermont Burlington Vermont USA – name: 12 Department of Head and Neck Oncology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA – name: 10 Center for Immunization and Infection Research in Cancer, H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA – name: 9 Department of Cancer Epidemiology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA – name: 8 Department of Gastrointestinal Oncology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA – name: 3 University of Kansas Cancer Center Kansas City Kansas USA – name: 7 Department of Oncologic Sciences University of South Florida Tampa Florida USA – name: 1 Department of Health Outcomes and Behavior H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA – name: 2 College of Medicine, University of South Florida Tampa Florida USA – name: 5 Cancer Control and Population Health Sciences Program University of Vermont Cancer Center Burlington Vermont USA – name: 6 Department of Public Health Sciences University of Miami Miller School of Medicine Miami Florida USA – name: 11 Department of Health Services, Research, and Management University of Florida Gainesville Florida USA |
Author_xml | – sequence: 1 givenname: Oliver T. orcidid: 0000-0003-2852-7106 surname: Nguyen fullname: Nguyen, Oliver T. email: oliver.nguyen@moffitt.org organization: H. Lee Moffitt Cancer Center and Research Institute – sequence: 2 givenname: Umberto orcidid: 0000-0002-7311-5736 surname: Donato fullname: Donato, Umberto organization: College of Medicine, University of South Florida – sequence: 3 givenname: Rachael surname: McCormick fullname: McCormick, Rachael organization: University of Kansas Cancer Center – sequence: 4 givenname: Maija surname: Reblin fullname: Reblin, Maija organization: University of Vermont Cancer Center – sequence: 5 givenname: Lindsay surname: Kim fullname: Kim, Lindsay organization: College of Medicine, University of South Florida – sequence: 6 givenname: Emma surname: Hume fullname: Hume, Emma organization: H. Lee Moffitt Cancer Center and Research Institute – sequence: 7 givenname: Amy K. surname: Otto fullname: Otto, Amy K. organization: University of Miami Miller School of Medicine – sequence: 8 givenname: Amir surname: Alishahi Tabriz fullname: Alishahi Tabriz, Amir organization: H. Lee Moffitt Cancer Center and Research Institute – sequence: 9 givenname: Jessica Y. surname: Islam fullname: Islam, Jessica Y. organization: Center for Immunization and Infection Research in Cancer, H. Lee Moffitt Cancer Center and Research Institute – sequence: 10 givenname: Young‐Rock orcidid: 0000-0002-0366-5687 surname: Hong fullname: Hong, Young‐Rock organization: University of Florida – sequence: 11 givenname: Kea surname: Turner fullname: Turner, Kea organization: H. Lee Moffitt Cancer Center and Research Institute – sequence: 12 givenname: Krupal B. surname: Patel fullname: Patel, Krupal B. organization: H. Lee Moffitt Cancer Center and Research Institute |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37090884$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks1uEzEQgFeoiJbSAy-ALHGBQ6h_1j_hUlUVhUiReoGz5fXOJg6OHWxvITcegWfkSXCSUrVI-OKR5_OnmdE8b45CDNA0Lwl-RzCm595FWiOmnjQnlEk1UTU-ehAfN2c5rzDGRFAhFH7WHDOJp1ip9qTx1y6YYJ3xqMQfzrqyRWYdwwItwfTIhB4FsF-RrRAktDHFQSh5nyhLcKlmEizcLaT8Hl0im2LOv3_-ymCLi6FqN87HgnIZ--2L5ulgfIazu_u0-XL94fPVp8n85uPs6nI-sZwpNbFikAMAp72hhBhs2cAUDMJ09XBl-5YIQ6kiVhCuupax2r4RXImhlwQkO21mB28fzUpvklubtNXROL1_iGmhTSrOetBcYFm_y7aOpu26qemNaKeDagW3A-lYdV0cXJuxW0Nva_fJ-EfSx5nglnoRbzXBhIip3FXz5s6Q4rcRctFrly14bwLEMWuqMOdECoYr-vofdBXHVKe4pxiVSnJSqbcHaj_sBMN9NQTr3U7o3U7o3U5U9tXD8u_JvxtQgfMD8N152P7fpOezG7pX_gFMcsNr |
CitedBy_id | crossref_primary_10_1016_j_jacr_2024_04_024 crossref_primary_10_1016_j_oor_2024_100580 crossref_primary_10_1007_s00520_024_08424_3 |
Cites_doi | 10.1007/s00520-020-05962-4 10.6004/jnccn.2019.7305 10.1007/s00520-021-06424-1 10.1200/JOP.19.00563 10.1093/jnci/djw205 10.1001/jamaoncol.2016.6307 10.1007/s40273-014-0169-3 10.1002/smi.2445 10.1001/archotol.133.5.464 10.1016/j.oraloncology.2021.105196 10.1002/cncr.28814 10.1200/JCO.2015.64.6620 10.1001/jamanetworkopen.2020.10651 10.1634/theoncologist.2012-0279 10.1158/1055-9965.EPI-20-0067 10.1016/j.oraloncology.2019.104521 10.1016/j.jacr.2019.07.014 10.1200/JOP.2017.024927 10.1016/j.oraloncology.2019.06.023 10.1093/annonc/mdz140 10.1200/JOP.2016.016337 10.1002/hed.26801 10.1001/jamaoncol.2020.5748 10.1002/pon.4079 10.1093/jncics/pkab033 10.1158/1055-9965.EPI-20-1157 10.1016/j.jval.2020.08.002 10.1016/j.jval.2013.10.004 10.1002/pon.5034 10.1016/j.pecinn.2021.100002 10.1016/j.bjoms.2011.07.026 10.1186/1758-3284-4-15 10.1007/s11764-014-0382-2 10.1200/OP.21.00706 10.1136/bmj.39335.541782.AD 10.1007/s00520-021-06036-9 10.7812/TPP/18‐084 10.1001/jamaoto.2018.3982 10.1016/j.urolonc.2020.06.030 10.1007/s11136-020-02721-0 10.1002/cncr.30369 |
ContentType | Journal Article |
Copyright | 2023 The Authors. published by Wiley Periodicals LLC on behalf of The Triological Society. 2023 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society. 2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2023 The Authors. published by Wiley Periodicals LLC on behalf of The Triological Society. – notice: 2023 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society. – notice: 2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P WIN NPM AAYXX CITATION 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1002/lio2.1038 |
DatabaseName | Wiley Online Library Open Access Wiley Online Library Free Content PubMed CrossRef ProQuest Central (Corporate) ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) Coronavirus Research Database ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Nguyen et al |
EISSN | 2378-8038 |
EndPage | 457 |
ExternalDocumentID | oai_doaj_org_article_5607310742664bb9ada649f8465cf1b3 10_1002_lio2_1038 37090884 LIO21038 |
Genre | researchArticle Journal Article |
GrantInformation_xml | – fundername: Internal department funding |
GroupedDBID | 0R~ 1OC 24P 53G 5VS 7X7 8FI 8FJ AAHHS AAZKR ABDBF ABUWG ACCFJ ACXQS ADBBV ADKYN ADZMN AEEZP AEQDE AFKRA AIWBW AJBDE ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU BCNDV BENPR BPHCQ BVXVI CCPQU EBS EJD FYUFA GROUPED_DOAJ HMCUK HYE IAO IHR INH KQ8 M~E O9- OK1 PIMPY PQQKQ PROAC RPM UKHRP WIN ITC NPM AAYXX CITATION 3V. 7XB 8FK AZQEC COVID DWQXO K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c5388-c6f7fee52da211a0c3f38ef6abbbb58cd416a2281c6158b433103a6586fd71e73 |
IEDL.DBID | RPM |
ISSN | 2378-8038 |
IngestDate | Tue Oct 22 15:11:30 EDT 2024 Tue Sep 17 21:30:55 EDT 2024 Tue Sep 17 17:33:44 EDT 2024 Thu Oct 10 19:45:19 EDT 2024 Thu Sep 26 19:59:16 EDT 2024 Wed Oct 23 09:45:48 EDT 2024 Sat Aug 24 01:21:58 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | caregivers financial toxicity head and neck cancer financial burden |
Language | English |
License | Attribution-NonCommercial-NoDerivs 2023 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5388-c6f7fee52da211a0c3f38ef6abbbb58cd416a2281c6158b433103a6586fd71e73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-0366-5687 0000-0002-7311-5736 0000-0003-2852-7106 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116977/ |
PMID | 37090884 |
PQID | 2803278751 |
PQPubID | 4370301 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5607310742664bb9ada649f8465cf1b3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10116977 proquest_miscellaneous_2805517630 proquest_journals_2803278751 crossref_primary_10_1002_lio2_1038 pubmed_primary_37090884 wiley_primary_10_1002_lio2_1038_LIO21038 |
PublicationCentury | 2000 |
PublicationDate | April 2023 |
PublicationDateYYYYMMDD | 2023-04-01 |
PublicationDate_xml | – month: 04 year: 2023 text: April 2023 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Hoboken |
PublicationTitle | Laryngoscope investigative otolaryngology |
PublicationTitleAlternate | Laryngoscope Investig Otolaryngol |
PublicationYear | 2023 |
Publisher | John Wiley & Sons, Inc Wiley |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley |
References | 2021; 7 2021; 43 2021; 5 2019; 95 2017; 3 2013; 27 2019; 30 2021; 29 2019; 17 2019; 16 2020; 16 2020; 101 2021; 1 2015; 9 2021; 30 2019; 145 2016; 34 2018; 24 2012; 50 2017; 109 2013; 18 2007; 335 2020; 3 2021; 115 2007; 133 2019; 23 2021; 39 2017; 13 2019; 28 2022; 30 2012; 28 2020; 23 2022; 1 2014; 17 2017; 123 2012; 4 2014; 120 2016; 25 2014; 32 2018; 14 2022; 18 2020; 29 e_1_2_11_10_1 e_1_2_11_32_1 e_1_2_11_31_1 e_1_2_11_30_1 e_1_2_11_36_1 e_1_2_11_14_1 e_1_2_11_13_1 e_1_2_11_35_1 e_1_2_11_12_1 e_1_2_11_34_1 e_1_2_11_11_1 e_1_2_11_33_1 e_1_2_11_7_1 e_1_2_11_29_1 e_1_2_11_6_1 e_1_2_11_28_1 e_1_2_11_5_1 e_1_2_11_27_1 e_1_2_11_26_1 e_1_2_11_3_1 e_1_2_11_2_1 Zafar SY (e_1_2_11_4_1) 2013; 27 Yezefski T (e_1_2_11_24_1) 2018; 24 e_1_2_11_21_1 Baddour K (e_1_2_11_22_1) 2021; 1 e_1_2_11_44_1 e_1_2_11_20_1 e_1_2_11_45_1 e_1_2_11_46_1 Mott NM (e_1_2_11_40_1) 2022; 18 e_1_2_11_47_1 e_1_2_11_25_1 e_1_2_11_41_1 e_1_2_11_9_1 e_1_2_11_23_1 e_1_2_11_42_1 e_1_2_11_8_1 e_1_2_11_43_1 e_1_2_11_18_1 e_1_2_11_17_1 e_1_2_11_16_1 e_1_2_11_15_1 e_1_2_11_37_1 e_1_2_11_38_1 e_1_2_11_39_1 e_1_2_11_19_1 |
References_xml | – volume: 13 start-page: e310 issue: 4 year: 2017 end-page: e318 article-title: Determinants of patient‐centered financial stress in patients with locally advanced head and neck cancer publication-title: J Oncol Pract – volume: 115 year: 2021 article-title: Association of significant financial burden with survival for head and neck cancer patients treated with radiation therapy publication-title: Oral Oncol – volume: 23 start-page: 18 year: 2019 end-page: 84 article-title: Evaluation of a novel financial navigator pilot to address patient concerns about medical care costs publication-title: Perm J – volume: 335 start-page: 806 issue: 7624 year: 2007 end-page: 808 article-title: Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies publication-title: BMJ – volume: 17 start-page: 1184 issue: 10 year: 2019 end-page: 1192 article-title: Financial burdens of cancer treatment: a systematic review of risk factors and outcomes publication-title: J Natl Compr Canc Netw – volume: 9 start-page: 30 issue: 1 year: 2015 end-page: 39 article-title: Long‐term workforce participation patterns following head and neck cancer publication-title: J Cancer Surviv – volume: 101 year: 2020 article-title: Patient‐reported financial toxicity and adverse medical consequences in head and neck cancer publication-title: Oral Oncol – volume: 28 start-page: 362 issue: 5 year: 2012 end-page: 367 article-title: First anxiety, afterwards depression: psychological distress in cancer patients at diagnosis and after medical treatment publication-title: Stress Health – volume: 43 start-page: 3062 issue: 10 year: 2021 end-page: 3075 article-title: The cost of cure: examining objective and subjective financial toxicity in head and neck cancer survivors publication-title: Head Neck – volume: 123 start-page: 476 issue: 3 year: 2017 end-page: 484 article-title: Measuring financial toxicity as a clinically relevant patient‐reported outcome: the validation of the COmprehensive score for financial toxicity (COST) publication-title: Cancer – volume: 24 start-page: S74 issue: 5 Suppl year: 2018 end-page: S79 article-title: Impact of trained oncology financial navigators on patient out‐of‐pocket spending publication-title: Am J Manag Care – volume: 4 start-page: 15 year: 2012 article-title: The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid publication-title: Head Neck Oncol – volume: 29 start-page: 5673 issue: 10 year: 2021 end-page: 5680 article-title: The association of health insurance literacy and numeracy with financial toxicity and hardships among colorectal cancer survivors publication-title: Support Care Cancer – volume: 29 start-page: 694 issue: 3 year: 2020 article-title: Reducing cancer‐related financial toxicity through financial navigation: results from a pilot intervention publication-title: Cancer Epidemiol Biomarkers Prev – volume: 34 start-page: 980 issue: 9 year: 2016 end-page: 986 article-title: Financial insolvency as a risk factor for early mortality among patients with cancer publication-title: J Clin Oncol – volume: 3 start-page: 817 issue: 6 year: 2017 end-page: 825 article-title: Resource use and Medicare costs during lay navigation for geriatric patients with cancer publication-title: JAMA Oncol – volume: 30 start-page: 3255 issue: 11 year: 2021 end-page: 3266 article-title: Feasibility of health‐related quality of life (HRQoL) assessment for cancer patients using electronic patient‐reported outcome (ePRO) in daily clinical practice publication-title: Qual Life Res – volume: 3 issue: 6 year: 2020 article-title: Association of the coronavirus disease 2019 (COVID‐19) outbreak with enrollment in cancer clinical trials publication-title: JAMA Netw Open – volume: 18 start-page: 381 issue: 4 year: 2013 end-page: 390 article-title: The financial toxicity of cancer treatment: a pilot study assessing out‐of‐pocket expenses and the insured cancer patient's experience publication-title: Oncologist – volume: 30 start-page: 217 issue: 1 year: 2022 end-page: 225 article-title: Correlates of financial toxicity in adult cancer patients and their informal caregivers publication-title: Support Care Cancer – volume: 29 start-page: 6109 issue: 10 year: 2021 end-page: 6117 article-title: Identifying a cut‐off score for the COST measure to indicate high financial toxicity and low quality of life among cancer patients publication-title: Support Care Cancer – volume: 23 start-page: 1592 issue: 12 year: 2020 end-page: 1598 article-title: Patient–provider discussion about cancer treatment costs and out‐of‐pocket spending: implications for shared decision making in cancer care publication-title: Value Health – volume: 18 start-page: e1100 issue: 7 year: 2022 end-page: e1113 article-title: Implementation and feasibility of an electronic health record–integrated patient‐reported outcomes symptom and needs monitoring pilot in ambulatory oncology publication-title: JCO Oncol Pract – volume: 7 start-page: 131 issue: 1 year: 2021 end-page: 132 article-title: Association of the COVID‐19 outbreak with patient willingness to enroll in cancer clinical trials publication-title: JAMA Oncol – volume: 5 issue: 3 year: 2021 article-title: Delivery of financial navigation services within National Cancer Institute‐designated cancer centers publication-title: JNCI Cancer Spectr – volume: 28 start-page: 863 issue: 4 year: 2019 end-page: 871 article-title: Cancer‐related financial hardship among head and neck cancer survivors: risk factors and associations with health‐related quality of life publication-title: Psychooncology – volume: 14 start-page: e122 issue: 2 year: 2018 end-page: e129 article-title: Pilot feasibility study of an oncology financial navigation program publication-title: J Oncol Pract – volume: 145 start-page: 239 issue: 3 year: 2019 end-page: 249 article-title: Comparison of the financial burden of survivors of head and neck cancer with other cancer survivors publication-title: JAMA Otolaryngol Head Neck Surg – volume: 32 start-page: 865 issue: 9 year: 2014 end-page: 882 article-title: The economic burden of head and neck cancer: a systematic literature review publication-title: Pharmacoeconomics – volume: 120 start-page: 3245 issue: 20 year: 2014 end-page: 3253 article-title: The development of a financial toxicity patient‐reported outcome in cancer: the COST measure publication-title: Cancer – volume: 18 start-page: e937 year: 2022 article-title: Financial hardship in patients with head and neck cancer publication-title: JCO Oncol Pract – volume: 50 start-page: 410 issue: 5 year: 2012 end-page: 416 article-title: Patients' perception of the financial impact of head and neck cancer and the relationship to health related quality of life publication-title: Br J Oral Maxillofac Surg – volume: 133 start-page: 464 issue: 5 year: 2007 end-page: 470 article-title: Patient‐reported factors associated with discontinuing employment following head and neck cancer treatment publication-title: Arch Otolaryngol Head Neck Surg – volume: 30 start-page: 669 issue: 4 year: 2021 end-page: 675 article-title: Current practices for screening and addressing financial hardship within the NCI Community oncology research program publication-title: Cancer Epidemiol Biomarkers Prev – volume: 30 start-page: 1061 issue: 7 year: 2019 end-page: 1070 article-title: Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications publication-title: Ann Oncol – volume: 17 start-page: 90 issue: 1 year: 2014 end-page: 97 article-title: Evaluating direct medical expenditures estimation methods of adults using the medical expenditure panel survey: an example focusing on head and neck cancer publication-title: Value Health – volume: 1 year: 2022 article-title: The DISCO app: a pilot test of a multi‐level intervention to reduce the financial burden of cancer through improved cost communication publication-title: PEC Innovation – volume: 109 issue: 2 year: 2017 article-title: Financial hardships experienced by cancer survivors: a systematic review publication-title: J Natl Cancer Inst – volume: 39 start-page: 77.e1 issue: 1 year: 2021 end-page: e77.e8 article-title: Feasibility and delivery of patient‐reported outcomes in clinical practice among racially diverse bladder and prostate cancer patients publication-title: Urol Oncol – volume: 1 start-page: P99 year: 2021 end-page: P100 article-title: Caregiver experience throughout head and neck cancer survivorship: longitudinal study publication-title: Otolaryngol Head Neck Surg – volume: 95 start-page: 187 year: 2019 end-page: 193 article-title: Understanding financial toxicity in head and neck cancer survivors publication-title: Oral Oncol – volume: 16 start-page: 1420 issue: 10 year: 2019 end-page: 1424 article-title: Pilot feasibility study of an oncology financial navigation program in brain cancer patients publication-title: J Am Coll Radiol – volume: 27 start-page: 80 issue: 2 year: 2013 end-page: 81 article-title: Financial toxicity, part I: a new name for a growing problem publication-title: Oncology – volume: 25 start-page: 1441 issue: 12 year: 2016 end-page: 1447 article-title: The financial impact of head and neck cancer caregiving: a qualitative study publication-title: Psychooncology – volume: 16 start-page: e529 issue: 6 year: 2020 end-page: e537 article-title: Health insurance literacy and financial hardship in women living with metastatic breast cancer publication-title: JCO Oncol Pract – ident: e_1_2_11_35_1 doi: 10.1007/s00520-020-05962-4 – ident: e_1_2_11_3_1 doi: 10.6004/jnccn.2019.7305 – ident: e_1_2_11_20_1 doi: 10.1007/s00520-021-06424-1 – ident: e_1_2_11_31_1 doi: 10.1200/JOP.19.00563 – ident: e_1_2_11_2_1 doi: 10.1093/jnci/djw205 – ident: e_1_2_11_25_1 doi: 10.1001/jamaoncol.2016.6307 – ident: e_1_2_11_12_1 doi: 10.1007/s40273-014-0169-3 – ident: e_1_2_11_44_1 doi: 10.1002/smi.2445 – ident: e_1_2_11_14_1 doi: 10.1001/archotol.133.5.464 – ident: e_1_2_11_17_1 doi: 10.1016/j.oraloncology.2021.105196 – ident: e_1_2_11_30_1 doi: 10.1002/cncr.28814 – volume: 1 start-page: P99 year: 2021 ident: e_1_2_11_22_1 article-title: Caregiver experience throughout head and neck cancer survivorship: longitudinal study publication-title: Otolaryngol Head Neck Surg contributor: fullname: Baddour K – ident: e_1_2_11_39_1 – volume: 27 start-page: 80 issue: 2 year: 2013 ident: e_1_2_11_4_1 article-title: Financial toxicity, part I: a new name for a growing problem publication-title: Oncology contributor: fullname: Zafar SY – ident: e_1_2_11_19_1 doi: 10.1200/JCO.2015.64.6620 – volume: 18 start-page: e937 year: 2022 ident: e_1_2_11_40_1 article-title: Financial hardship in patients with head and neck cancer publication-title: JCO Oncol Pract contributor: fullname: Mott NM – ident: e_1_2_11_42_1 doi: 10.1001/jamanetworkopen.2020.10651 – ident: e_1_2_11_5_1 doi: 10.1634/theoncologist.2012-0279 – ident: e_1_2_11_26_1 doi: 10.1158/1055-9965.EPI-20-0067 – ident: e_1_2_11_15_1 doi: 10.1016/j.oraloncology.2019.104521 – ident: e_1_2_11_27_1 doi: 10.1016/j.jacr.2019.07.014 – ident: e_1_2_11_28_1 doi: 10.1200/JOP.2017.024927 – ident: e_1_2_11_8_1 doi: 10.1016/j.oraloncology.2019.06.023 – ident: e_1_2_11_6_1 doi: 10.1093/annonc/mdz140 – volume: 24 start-page: S74 issue: 5 year: 2018 ident: e_1_2_11_24_1 article-title: Impact of trained oncology financial navigators on patient out‐of‐pocket spending publication-title: Am J Manag Care contributor: fullname: Yezefski T – ident: e_1_2_11_18_1 doi: 10.1200/JOP.2016.016337 – ident: e_1_2_11_10_1 doi: 10.1002/hed.26801 – ident: e_1_2_11_43_1 doi: 10.1001/jamaoncol.2020.5748 – ident: e_1_2_11_21_1 doi: 10.1002/pon.4079 – ident: e_1_2_11_29_1 doi: 10.1093/jncics/pkab033 – ident: e_1_2_11_45_1 doi: 10.1158/1055-9965.EPI-20-1157 – ident: e_1_2_11_46_1 doi: 10.1016/j.jval.2020.08.002 – ident: e_1_2_11_7_1 doi: 10.1016/j.jval.2013.10.004 – ident: e_1_2_11_11_1 doi: 10.1002/pon.5034 – ident: e_1_2_11_47_1 doi: 10.1016/j.pecinn.2021.100002 – ident: e_1_2_11_41_1 doi: 10.1016/j.bjoms.2011.07.026 – ident: e_1_2_11_16_1 doi: 10.1186/1758-3284-4-15 – ident: e_1_2_11_13_1 doi: 10.1007/s11764-014-0382-2 – ident: e_1_2_11_36_1 doi: 10.1200/OP.21.00706 – ident: e_1_2_11_33_1 doi: 10.1136/bmj.39335.541782.AD – ident: e_1_2_11_32_1 doi: 10.1007/s00520-021-06036-9 – ident: e_1_2_11_23_1 doi: 10.7812/TPP/18‐084 – ident: e_1_2_11_9_1 doi: 10.1001/jamaoto.2018.3982 – ident: e_1_2_11_38_1 doi: 10.1016/j.urolonc.2020.06.030 – ident: e_1_2_11_37_1 doi: 10.1007/s11136-020-02721-0 – ident: e_1_2_11_34_1 doi: 10.1002/cncr.30369 |
SSID | ssj0001626680 |
Score | 2.2905316 |
Snippet | Objectives
Head and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has... Head and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has concentrated on... Abstract Objectives Head and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has... ObjectivesHead and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has concentrated... Our pilot study administered the Comprehensive Score for Financial Toxicity (COST) measure to head and neck cancer patients and their caregivers. We found that... Abstract Objectives Head and neck cancer (HNC) patients experience greater financial toxicity than other cancer patients. Research on financial toxicity has... |
SourceID | doaj pubmedcentral proquest crossref pubmed wiley |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 450 |
SubjectTerms | Cancer therapies Caregivers Clinical outcomes Consent Ethnicity Family income Feasibility studies financial burden financial toxicity Head & neck cancer head and neck cancer Head and Neck, and Tumor Biology Health insurance Hispanic Americans Households Missing data Original Research Patients Questionnaires |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB5VnHqpWvFoKK0M4sAlIrHzcLhR1BUgoJcicbP8pKuuEsQuUo_8BH4jv4QZJ7vaFa16aU5RbCWTmdjzOTP-BmC_tL72jXZpQN-ACxRcsFK0Jg3OSl14l1lDm5Mvr6rT6-L8prxZKvVFOWE9PXCvuEP0yLWgrEH0JIUxeFtdFU1At1nakJue5zMvlxZT8e8K4vRKZnMqoYwfTsYdj2zgKw4o8vT_CVy-zpFcxq7R-Yzew7sBNbLjXtoP8Ma36zAZzdky2Kz7PbaIp1msHcRwgnVMt4613v5ilgx7zwYG1WlsiPEBRmlftzEx44gdsyjv8-PTNGZn0fPuxpNuxiID7QZcj779ODlNh-IJqcU5TKa2CnXwvuROo350ZkUQ0odKGzxKKlmUV5pzmVvENNLQxqlMaMQjVXB17muxCWtt1_qPwGTDtTCIBWwjioL7xjVeNj4XphbB8ZDA3lyj6q7nyFA9GzJXpHZFak_gK-l60YForeMFNLYajK3-ZewEduaWUsNYmyqqr8Vx3inzBHYXzThKKPShW989xD4IDXEuzRLY6g27kETUGSV7FQnIFZOviLra0o5_RibunMJYiKATOIhfx99fX12cfed0sv0_9PAJ3lLZ-z6DaAfWZvcP_jOCo5n5EsfBCya2Dgw priority: 102 providerName: Directory of Open Access Journals – databaseName: Coronavirus Research Database dbid: COVID link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7B9sKFh3iFFmQQBy5pEzsPhwsqhVWLgF4o6s2yHbssrZLtblZC_HpmnGTL8jqwp2gdKXZmPP7s-fINwPPcutJVuo49rg24QcENK2VrYl9bqTNXJ9bQx8kfPhaHJ9m70_x0OHBbDrTKMSaGQF23ls7I96iKEkfvytNX88uYqkZRdnUooXEdtoTEnc4Etg6OPx-9uTplQbxeyGSUFEr43sWs5UEVfGMhCnr9fwKZv3Mlf8awYRGa3gI1dr_nnpzvrjqza7__ouz4_-O7DTcHfMr2e4e6A9dccxe-TkddDta132YWkTsLVYoYhvKa6aZmjbPnzJILLdig1boMDSETwYhgdhYoIC_ZPgtvJF4GFhg9bT67aDsWlG7vwcn07aeDw3go0hBbjJUytoUvvXM5rzXuJXVihRfS-UIb_OVUGiktNOcytYidpKEPtBKhEfcUvi5TV4r7MGnaxj0EJiuuhUHMYSuRZdxVdeVk5VJhSuFr7iN4NlpMzXstDtWrLnNFZlVk1gheky3XN5B8dvijXZypYTYqhHmlICoqekdmDPqqLrLKIxbLrU-NiGBnNJIa5vRSXVkogqfrZpyNlGLRjWtX4R6EoBizkwge9I6z7okoEyKVZRHIDZfa6OpmSzP7EhS_U0qXIVKP4EXwvr8PX70_OuZ08ejfQ9iGGxzhWs9B2oFJt1i5xwivOvNkmEM_AHnpKR0 priority: 102 providerName: ProQuest – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6V9sIFgaAQKMggDr1ETew8HDiVqqu2Ko8DlXqz_CwrVkm1u5U48hP4jfwSZpxHWQESOUWxozgznvFne_wNwOvS-to32qUBxwacoOCElXZr0uCs1IV3mTV0OPn9h-rkoji7LC-34O14Fqbnh5gW3Mgyor8mA9dmdXBLGrqYdzzSe9-BHYQ1kro0Lz7dLrAgVK9i5jQucKYksebILJTxg-ntjfEo0vb_DWv-GTL5O5SNY9HsPtwbQCQ77LX-ALZ8-xAWs5E8g627b3OL8JrFVEIM_a1junWs9fYrs6TnJRsIVVexIG4XMIoCu4pxGm_YIYvt_fn9xyoGa9H3rueLbs0iIe0juJgdfz46SYdcCqlFlyZTW4U6eF9yp3HKpzMrgpA-VNrgVVIGo7zSnMvcIsSRhs5RZUIjPKmCq3Nfi13YbrvWPwEmG66FQWhgG1EU3Deu8bLxuTC1CI6HBF6NElXXPWWG6smRuSKxKxJ7Au9I1lMFYrmOD7rllRqMRiEaqwVFjKImC2OwS-mqaAJCptKG3IgE9kZNqcH0VorSbXF0Q2WewMupGI2GdkJ067ubWAeRIrrWLIHHvWKnlog6o9ivIgG5ofKNpm6WtPMvkZg7p10tBNQJ7Mfe8e_fV-enHzndPP3_qs_gLuW678OG9mB7vbzxzxERrc2L2PN_AdC7CIk priority: 102 providerName: Wiley-Blackwell |
Title | Financial toxicity among head and neck cancer patients and their caregivers: A cross‐sectional pilot study |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Flio2.1038 https://www.ncbi.nlm.nih.gov/pubmed/37090884 https://www.proquest.com/docview/2803278751 https://www.proquest.com/docview/2805517630/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC10116977 https://doaj.org/article/5607310742664bb9ada649f8465cf1b3 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9MwGH61jgsXBOIrY1QGceCSNbGT2OG2lVUbsK0ghnqLbMceEV1StZ3EkZ_Ab-SX8NpJqlXAhRycKI5kx68_HtuPnxfgVaoNN7ksQ4tjA05QcMLqdmtCW2ohE1NGWrnDyWfn2cll8m6WznYg68_CeNK-VtVBPb8-qKuvnlu5uNajnic2mp6NY7d7gMBlNIABZ-zWHN2vrCBGz0TUywhFdDSvGuqVwLcGH6_R_zdg-Sc_8jZu9QPP5D7c6xAjOWxz9gB2TP0Q5pNeKYOsm--VRixNvN8ggp1rSWRdktrob0Q7oy5Jp5668hF-b4A4yteVJ2W8IYfE5_fXj58rz8xy6S2qebMmXn32EVxOjj-PT8LOcUKosf8Soc4st8aktJQ4v5ORZpYJYzOp8Eqdu6I4k5SKWCOeEcodmoqYRCyS2ZLHhrPHsFs3tXkKRORUMoU4QOcsSajJy9yI3MRMcWZLagN42ZdosWj1MYpWCZkWrtgLV-wBHLmy3nzgJK39i2Z5VXSGLRB6cebooWi9RCmsPzJLcov4KNU2ViyA_d5SRdfOVoXzrUWxz0njAF5sorGFuG0PWZvmxn-DsBD70SiAJ61hNzlhPHJEryQAsWXyraxux2Cl9CrcfSUM4LWvHf_-_eLD6QV1D3v_n8ozuOsc3becoX3YXS9vzHOEQ2s1hAFNphjyGR_CnaPj8-knvI8vvpy-HfolBgzffxRD30p-A66ZFQ8 |
link.rule.ids | 230,315,733,786,790,870,891,2115,11589,12083,21416,27955,27956,31752,31753,33777,33778,38549,43343,43838,43928,46085,46509,50847,50956,53825,53827,74100,74657,74767 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7B9gAXHuLRQAGDOHBJm9h5OFxQKay20MelRb1ZfpalVbLsZiXEr2fsJFuW14E9rdaW1s6Mx589X74BeJlrW9pKmtjh3oAHFDyw-mxN7IzmMrMm0cq_nHx4VExOsw9n-Vl_4bboaZVDTAyB2jTa35Hv-CpKFL0rT9_Mvsa-apTPrvYlNK7DBm6slI9gY-_40_67q1sWxOsFTwZJoYTuXE4bGlTB1zaioNf_J5D5O1fyZwwbNqHxbRDD8DvuycX2slXb-vsvyo7_P787cKvHp2S3c6i7cM3W9-DLeNDlIG3zbaoRuZNQpYhgKDdE1obUVl8Q7V1oTnqt1kVoCJkI4glm54EC8prskvBE4kVggfl_m00vm5YEpdv7cDp-f7I3ifsiDbHGWMljXbjSWZtTI_EsKRPNHOPWFVLhJ_elkdJCUspTjdiJK_-CVsIk4p7CmTK1JXsAo7qp7SYQXlHJFGIOXbEso7YyleWVTZkqmTPURfBisJiYdVocolNdpsKbVXizRvDW23LVwctnhx-a-bnoV6NAmFcyT0VF78iUQl-VRVY5xGK5dqliEWwNRhL9ml6IKwtF8HzVjKvRp1hkbZtl6IMQFGN2EsHDznFWI2Fl4kllWQR8zaXWhrreUk8_B8Xv1KfLEKlH8Cp439-nLw72j6n_8ujfU3gGNyYnhwfY_ejjY7hJEbp1fKQtGLXzpX2CUKtVT_v19AN85SwE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BKyEuPMQrpYBBHLikm9h5ckGlZdXyaDlQ1FtkO3ZZtkq2u1kJ8euZcZwty-tETlFsKXFmPP6c-fINwPNUm9yUsg4trg24QcENK2VrQlvrQiamjrSin5M_HGUHJ8nb0_TU858WnlY5xEQXqOtW0zfyEVVR4uhdaTyynhbxcX_8anYRUgUpyrT6chpXYRMhcoYbsc2948-H-5dfXBC7Z0U0yAtFfHQ-ablTCF9blJx2_58A5--8yZ_xrFuQxjdhOgyl56FMd5ad2tHff1F5_D9jvQU3PG5lu72j3YYrprkDX8eDXgfr2m8TjYieuepFDEN8zWRTs8boKdPkWnPmNVwXrsFlKBgRz84cNeQl22Xu7YQLxw6ju80m523HnALuXTgZv_m0dxD64g2hxhhahDqzuTUm5bXEPaaMtLCiMDaTCo-USibFmeS8iDViqkLRj1uRkIiHMlvnscnFPdho2sY8AFaUXAqFWESXIkm4KevSFKWJhcqFrbkN4NlgvWrWa3RUvRozr8jEFZk4gNdk11UHktV2F9r5WeVnaYXwLxdEUUVPSZRCH5ZZUlrEaKm2sRIBbA8Gq_xcX1SX1grg6aoZZymlXmRj2qXrg9AUY3kUwP3eiVZPIvKIyGZJAMWae6096npLM_nilMBjSqMhgg_ghfPEvw-_en94zOlk699DeALX0NWw99G7h3CdI6LraUrbsNHNl-YRIrBOPfZT6wfduzTH |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Financial+toxicity+among+head+and+neck+cancer+patients+and+their+caregivers%3A+A+cross-sectional+pilot+study&rft.jtitle=Laryngoscope+investigative+otolaryngology&rft.au=Nguyen%2C+Oliver+T&rft.au=Donato%2C+Umberto&rft.au=McCormick%2C+Rachael&rft.au=Reblin%2C+Maija&rft.date=2023-04-01&rft.issn=2378-8038&rft.eissn=2378-8038&rft.volume=8&rft.issue=2&rft.spage=450&rft_id=info:doi/10.1002%2Flio2.1038&rft_id=info%3Apmid%2F37090884&rft.externalDocID=37090884 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2378-8038&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2378-8038&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2378-8038&client=summon |